A small molecule NRF2 activator BC-1901S ameliorates inflammation through DCAF1/NRF2 axis
NRF2 is a master regulator of cellular anti-oxidant and anti-inflammatory responses, and strategies to augment NRF2-dependent responses may beneficial in many diseases. Basal NRF2 protein level is constrained by constitutive KEAP1-mediated degradation, but in the presence of electrophiles, NRF2 ubiq...
Main Authors: | Yanwen Chen, John W. Evankovich, Travis B. Lear, Ferhan Tuncer, Jason R. Kennerdell, Daniel P. Camarco, Morgan S. Shishido, Yuan Liu, Bill B. Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231720302962 |
Similar Items
-
Doxorubicin promotes breast cancer cell migration and invasion via DCAF13
by: Zhaoran Sun, et al.
Published: (2022-01-01) -
AMPK-Mediated Phosphorylation of Nrf2 at S374/S408/S433 Favors Its βTrCP2-Mediated Degradation in KEAP1-Deficient Cells
by: Eleni Petsouki, et al.
Published: (2023-08-01) -
Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report
by: Jeffery L. Clothier, et al.
Published: (2022-05-01) -
Competition of nuclear factor-erythroid 2 factors related transcription factor isoforms, Nrf1 and Nrf2, in antioxidant enzyme induction
by: Nikolai L. Chepelev, et al.
Published: (2013-01-01) -
Case Report: A Deletion Variant in the DCAF17 Gene Underlying Woodhouse-Sakati Syndrome in a Chinese Consanguineous Family
by: Guangmin Chen, et al.
Published: (2021-09-01)